Study on the removal of amyloid plaque by nano-gold in the treatment of neurodegenerative disease-alzheimer's disease

As a complex neurological disease, the treatment of Alzheimer's disease (AD) is a global challenge. Compared with traditional drug therapy, a novel therapeutic tool, inorganic nanoparticles combined with photothermal therapy (PTT) can decompose amyloid beta-protein (A beta) fibrils and inhibit A beta aggregation, alleviating AD symptoms. In this study, MoS2@Au NPs composite nanoparticles were constructed by combining sulfhydryl-modified Au NPs and MoS2 nanosheets. In vitro experiments showed that the composite nanoparticles could degrade insoluble A beta fibers to soluble monomers and alleviate neurotoxicity. Additionally, the excellent biocompatibility and biosafety of MoS2@Au NPs reduced the damaging effects on nerve cells, and the AD model mice benefited from the treatment with MoS2@Au NPs, which significantly improved their learning and cognitive abilities and thus reduced the disease. More importantly, MoS2@Au NPs combined with PTT effectively curbed the inflammatory response and slowed down the course of AD.